Butylbiguanide concentration in plasma, liver, and intestine after intravenous and oral administration to man.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001645:Biguanides / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use / Q000652:urine; D002250:Carbon Radioisotopes; D003920:Diabetes Mellitus / Q000188:drug therapy; D004058:Diffusion; D005260:Female; D006207:Half-Life; D006801:Humans; D007275:Injections, Intravenous; D007408:Intestinal Absorption; D007413:Intestinal Mucosa / Q000378:metabolism*; D007444:Inulin / Q000378:metabolism; D007668:Kidney / Q000378:metabolism; D007700:Kinetics; D008099:Liver / Q000378:metabolism*; D008297:Male; D008433:Mathematics; D008875:Middle Aged; D008954:Models, Biological
D001645:Biguanides; D002250:Carbon Radioisotopes; D007444:Inulin